Notice Information
Notice Title
INTERVENTIONAL CARDIOLOGY, INTERVENTIONAL RADIOLOGY AND INTERVENTIONAL NEURORADIOLOGY, CARDIAC RHYTHM MANAGEMENT AND ELECTROPHYSIOLOGY
Notice Description
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 840,000,000 GBP to 1,200,000,000 GBP in the first twenty four months of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
Lot Information
Interventional Cardiology & Radiology
Interventional Cardiology products are used to support cardiac related procedures set in a catheter laboratory environment. Interventional Radiology refers to a range of techniques which rely on the use of radiological image guidance to precisely target therapy by using catheters, wires, balloons, stents, etc. Additional information: It is anticipated that in the first twenty four months of the Framework Agreement the value of purchases in this Lot will be circa 410,000,000 GBP. For the full 48 month term (if extended) the anticipated value is circa 902,000,000 GBP.
Options: This Framework Agreement will have an initial term of twenty four months with an option to extend incrementally for up to a total period of forty eight months.
Interventional NeuroradiologyInterventional Neuroradiology products are used to support minimally invasive procedures used to treat or diagnose diseases using image guidance, for example, haemoragic and ischemic strokes. Additional information: It is anticipated that in the first 24 months of the Framework Agreement the value of purchases in this Lot will be circa 60,000,000 GBP. For the full 48 month term (if extended) the anticipated value is circa 140,000,000 GBP.
Options: This Framework Agreement will have an initial term of twenty four months with an option to extend incrementally for up to a total period of forty eight months.
Cardiac Rhythm ManagementCardiac Rhythm Management devices perform many functions, including bradycardia pacing, monitoring for arrhythmias, cardiac resynchronisation for heart failure, defibrillation and anti-tachycardia pacing for tachyarrhythmias. Additional information: It is anticipated that in the first 24 months of the Framework Agreement the value of purchases in this Lot will be circa 530,000,000 GBP. For the full 48 month term (if extended) the anticipated value is circa 1,180,000,000 GBP.
Options: This Framework Agreement will have an initial term of twenty four months with an option to extend incrementally for up to a total period of forty eight months.
ElectrophysiologyElectrophysiology is the study of the heart's electrical system and includes intra-cardiac sensing, endocardial recording, stimulation and pacing to evaluate and diagnose cardiac arrhythmias. It includes ablation treatment undertaken during minimally invasive or cardiac surgical procedures, to treat cardiac arrhythmias by impairing or destroying diseased areas of cardiac tissue of a beating heart to interrupt abnormal electrical circuits of the heart. Ablation techniques include but are not limited to the use of radiofrequency, cryotherapy, irreversible electroporation, microwave, ultrasound, lasers and chemical energy. This Lot is or the supply of Electrophysiology devices, capital equipment, software, accessories and associated products and services, including but not limited to Maintenance, Servicing and Repair services, Rental, Purchase plan, Consultancy, Clinical and Mobile Cardiac Catheterisation Laboratory services. Additional information: It is anticipated that in the first 24 months of the Framework Agreement the value of purchases in this Lot will be circa 120000000 GBP. For the full 48 month term (if extended) the anticipated value is circa 280000000 GBP.
Options: This Framework Agreement will have an initial term of twenty four months with an option to extend incrementally for up to a total period of forty eight months.
Occluders, Vascular Appendage, Septal and Associated DevicesThe devices in this Lot are implanted using a transcatheter procedure. This is a minimally invasive cardiac repair procedure whereby a device is passed through a catheter, guided to and deployed in the heart. Additional information: It is anticipated that in the first 24 months of the Framework Agreement the value of purchases in this Lot will be circa 10,000,000 GBP. For the full 48 month term (if extended) the anticipated value is circa 21,000,000 GBP.
Options: This Framework Agreement will have an initial term of twenty four months with an option to extend incrementally for up to a total period of forty eight months.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-02cc0b
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/033148-2022
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
32 - Radio, television, communication, telecommunication and related equipment
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
32354100 - Radiology film
33000000 - Medical equipments, pharmaceuticals and personal care products
33100000 - Medical equipments
33111600 - Radiography devices
33111730 - Angioplasty supplies
33111740 - Angioplasty devices
33123000 - Cardiovascular devices
33124000 - Diagnostics and radiodiagnostic devices and supplies
33124100 - Diagnostic devices
33124110 - Diagnostic systems
33124120 - Diagnostic ultrasound devices
33124130 - Diagnostic supplies
33124200 - Radiodiagnostic devices
33124210 - Radiodiagnostic supplies
33140000 - Medical consumables
33141210 - Balloon catheters
33141220 - Cannulae
33141230 - Dilator
33141240 - Catheter accessories
33141310 - Syringes
33141320 - Medical needles
33141322 - Arterial needles
33141323 - Biopsy needles
33141324 - Dialysis needles
33141325 - Fistula needles
33141326 - Radiology procedural needles
33141327 - Vented needles
33182000 - Cardiac support devices
33182230 - Ventricle
33184500 - Coronary endoprostheses
33190000 - Miscellaneous medical devices and products
85121231 - Cardiology services
Notice Value(s)
- Tender Value
- £3,000,000,000 £1B-£10B
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £2,523,000,000 £1B-£10B
Notice Dates
- Publication Date
- 22 Nov 20223 years ago
- Submission Deadline
- 20 Sep 2021Expired
- Future Notice Date
- Not specified
- Award Date
- 28 Oct 20223 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS Supply Chain Operated by Health Solutions Team Limited acting as agent of Supply Chain Coordination Ltd (SCCL)
- Additional Buyers
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 6LH
- Postcode Area
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI44 Lewisham and Southwark
- Delivery Location
- Not specified
-
- Local Authority
- Southwark
- Electoral Ward
- St George's
- Westminster Constituency
- Bermondsey and Old Southwark
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.